Jennifer Woyach
MD
Associate Professor of Medicine
👥Biography 个人简介
Jennifer Woyach at Ohio State is an expert in BTK inhibitor resistance in CLL and has contributed to the development of next-generation BTK inhibitors including acalabrutinib. Her research characterizing acquired BTK and PLCG2 mutations that cause ibrutinib resistance, and her clinical trials of more selective BTK inhibitors like acalabrutinib and zanubrutinib designed to overcome some resistance mechanisms, have shaped the BTK inhibitor landscape in CLL.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jennifer Woyach 的研究动态
Follow Jennifer Woyach's research updates
留下邮箱，当我们发布与 Jennifer Woyach（Ohio State University Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment